However, the decreases observed in the irbesartan monotherapy group did not reach statistical significance across any of the evaluated leads ( P > .05).
← all excerpts
Antihypertensive and anti-ischemic effects of diltiazem in patients with primary hypertension.
1
0.0500
0.0500